Stempeutics Receives Japan Process Patent for its Novel Stem Cell Drug … – PR Newswire (press release)
Livemint |
Stempeutics Receives Japan Process Patent for its Novel Stem Cell Drug …
PR Newswire (press release) Commenting on the Japan patent, Mr. B N Manohar, CEO of Stempeutics, said, "The new patent strengthens our position in Japan, which has created an accelerated development path for stem cell therapies. The new regenerative medicine law implemented … Cipla JV Gets Process Patent for Stem Cell Drug From Japan Stempeutics gets process patent from Japan for stem cell-based drug Stempeutics receives ODD in EU for its novel stem cell drug “Stempeucel” |
